Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-J stent-related lower urinary symptoms

Advances in Urology

Volumn , Issue , 2013, Pages

  Shalaby, Essam ^a,b   Ahmed, Abul Fotouh ^c,d   Maarouf, Aref ^e,f   Yahia, Iman ^a,g   Ali, Mohamed ^a   Ghobish, Ammar ^a,g  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b Al Kharj   (Saudi Arabia)

^c AL AZHAR UNIVERSITY   (Egypt)

^d PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e ZAGAZIG UNIVERSITY   (Egypt)

^f King Abdallah Hospital   (Saudi Arabia)

^g Department of Urology   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84887435157     PISSN: 16876369     EISSN: 16876377     Source Type: Journal    
DOI: 10.1155/2013/752382     Document Type: Article

References (35)

1. Knudsen B. E., Beiko D. T., Denstedt J. D., Stenting after ureteroscopy: pros and cons. Urologic Clinics of North America 2004 31 1 173 180 2-s2.0-1242316253 10.1016/S0094-0143(03)00091-0 (Pubitemid 38229999)
2. Chew B. H., Knudsen B. E., Denstedt J. D., The use of stents in contemporary urology. Current Opinion in Urology 2004 14 2 111 115 2-s2.0-1542284702 10.1097/00042307-200403000-00011 (Pubitemid 38315405)
3. Joshi H. B., Stainthorpe A., Keeley F. X. Jr., Macdonagh R., Timoney A. G., Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. Journal of Endourology 2001 15 2 151 154 2-s2.0-0035074219 (Pubitemid 32290834)
4. Joshi H. B., Newns N., Stainthorpe A., MacDonagh R. P., Keeley F. X. Jr., Timoney A. G., Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. Journal of Urology 2003 169 3 1060 1064 2-s2.0-0037362830 10.1097/01.ju.0000049198.53424.1d (Pubitemid 36188159)
5. Sighinolfi M. C., Micali S., de Stefani S., Mofferdin A., Grande A., Giacometti M., Ferrari N., Rivalta M., Bianchi G., Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. Journal of Urology 2007 178 1 229 231 2-s2.0-34250167237 10.1016/j.juro.2007.03.039 (Pubitemid 46898482)
6. Thomas R., Indwelling ureteral stents: impact of material and shape on patient comfort. Journal of Endourology 1993 7 2 137 140 2-s2.0-0027324686 (Pubitemid 23159581)
7. Wang C.-J., Huang S.-W., Chang C.-H., Effects of specific α -1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study. Urological Research 2009 37 3 147 152 2-s2.0-67650035127 10.1007/s00240-009-0182-8
8. Choo M.-S., Lee J. Z., Lee J. B., Kim Y.-H., Jung H. C., Lee K.-S., Kim J. C., Seo J. T., Paick J.-S., Kim H.-J., Na Y. G., Lee J. G., Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study. International Journal of Clinical Practice 2008 62 11 1675 1683 2-s2.0-54049150815 10.1111/j.1742-1241.2008.01898.x
9. Lee Y. J., Huang K. H., Yang H. J., Chang H. C., Chen J., Yang T. K., Solifenacin improves double-J stent-related symptomsin both genders following uncomplicated ureteroscopic lithotripsy. Urolithiasis 2013 41 247 252 10.1007/s00240-013-0554-y
10. Ugur K., Bilal E., Murat T., Gokhan F., Fatih T., Aydin O., Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Canadian Urological Association Journal 2012 6 6 234 237
11. Shibasaki M., Sudoh K., Inagaki O., Uchida W., Honda K., Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetized dogs. Journal of Autonomic Pharmacology 1992 12 4 263 268 2-s2.0-0026652997
12. Vardy M. D., Mitcheson H. D., Samuels T.-A., Wegenke J. D., Forero-Schwanhaeuser S., Marshall T. S., He W., Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT-a double-blind, placebo-controlled trial. International Journal of Clinical Practice 2009 63 12 1702 1714 2-s2.0-70449458012 10.1111/j.1742-1241.2009.02209.x
13. Ho C.-H., Chang T.-C., Lin H.-H., Liu S.-P., Huang K.-H., Yu H.-J., Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms. Journal of the Formosan Medical Association 2010 109 10 702 708 2-s2.0-77958115871 10.1016/S0929-6646(10)60114-3
14. Joshi H. B., Stainthorpe A., MacDonagh R. P., Keeley F. X. Jr., Timoney A. G., Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. Journal of Urology 2003 169 3 1065 1069 2-s2.0-0037364239 10.1097/01.ju.0000048980.33855.90 (Pubitemid 36188160)
15. Byrne R. R., Auge B. K., Kourambas J., Munver R., Delvecchio F., Preminger G. M., Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. Journal of Endourology 2002 16 1 9 13 2-s2.0-0036199106 (Pubitemid 34215520)
16. Duvdevani M., Chew B. H., Denstedt J. D., Minimizing symptoms in patients with ureteric stents. Current Opinion in Urology 2006 16 2 77 82 2-s2.0-33744999000 10.1097/01.mou.0000193375.29942.0f (Pubitemid 43964565)
17. Damiano R., Autorino R., de Sio M., Giacobbe A., Palumbo I. M., D'Armiento M., Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. Journal of Endourology 2008 22 4 651 655 2-s2.0-42249093160 10.1089/end.2007.0257 (Pubitemid 351550748)
18. Rane A., Saleemi A., Cahill D., Sriprasad S., Shrotri N., Tiptaft R., Have stent-related symptoms anything to do with placement technique? Journal of Endourology 2001 15 7 741 745 2-s2.0-0034798124 (Pubitemid 32954386)
19. Beiko D. T., Knudsen B. E., Denstedt J. D., Advances in ureteral stent design. Journal of Endourology 2003 17 4 195 199 2-s2.0-0037982667 (Pubitemid 36666246)
20. Dunn M. D., Portis A. J., Kahn S. A., Yan Y., Shalhav A. L., Elbahnasy A. M., Bercowsky E., Hoenig D. M., Wolf J. S. Jr., Mcdougall E. M., Clayman R. V., Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. Journal of Endourology 2000 14 2 195 202 2-s2.0-0034120299 (Pubitemid 30198472)
21. Ho C.-H., Chen S.-C., Chung S.-D., Lee Y.-J., Chen J., Yu H.-J., Huang K.-H., Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. Journal of Endourology 2008 22 7 1427 1431 2-s2.0-50649121815 10.1089/end.2008.0037
22. Damiano R., Autorino R., de Sio M., Cantiello F., Quarto G., Perdonà S., Sacco R., D'Armiento M., Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. European Urology 2005 48 4 673 678 2-s2.0-24644432525 10.1016/j.eururo.2005.06. 006 (Pubitemid 41278595)
23. Chew B. H., Knudsen B. E., Nott L., Pautler S. E., Razvi H., Amann J., Denstedt J. D., Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. Journal of Endourology 2007 21 9 1069 1075 2-s2.0-35349030327 10.1089/end.2006.0252 (Pubitemid 47608924)
24. Lang R. J., Davidson M. E., Exintaris B., Pyeloureteral motility and ureteral peristalsis: essential role of sensory nerves and endogenous prostaglandins. Experimental Physiology 2002 87 2 129 146 2-s2.0-0036200410 10.1113/eph8702290 (Pubitemid 34257028)
25. Wang C.-J., Huang S.-W., Chang C.-H., Effects of tamsulosin on lower urinary tract symptoms due to double-j stent: a prospective study. Urologia Internationalis 2009 83 1 66 69 2-s2.0-68549133417 10.1159/000224871
26. Agarwal A., Dhiraaj S., Singhal V., Kapoor R., Tandon M., Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. British Journal of Anaesthesia 2006 96 3 377 380 2-s2.0-33244488049 10.1093/bja/ael003 (Pubitemid 43280630)
27. Lim K. T., Kim Y. T., Lee T. Y., Park S. Y., Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean Journal of Urology 2011 52 7 485 488 2-s2.0-79961235958 10.4111/kju.2011.52.7.485
28. Joshi H. B., Okeke A., Newns N., Keeley F. X. Jr., Timoney A. G., Characterization of urinary symptoms in patients with ureteral stents. Urology 2002 59 4 511 516 2-s2.0-0036129140 10.1016/S0090-4295(01)01644-2 (Pubitemid 34249872)
29. Deliveliotis C., Chrisofos M., Gougousis E., Papatsoris A., Dellis A., Varkarakis I. M., Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006 67 1 35 39 2-s2.0-30344455360 10.1016/j.urology.2005.07.038 (Pubitemid 43069251)
30. Beddingfield R., Pedro R. N., Hinck B., Kreidberg C., Feia K., Monga M., Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. Journal of Urology 2009 181 1 170 176 2-s2.0-57149092292 10.1016/j.juro.2008.09.026
31. Kuyumcuoglu U., Eryildirim B., Tuncer M., Faydaci G., Tarhan F., Ozgül A., Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Canadian Urological Association Journa 2012 6 6 E234 E237
32. Norris R. D., Sur R. L., Springhart W. P., Marguet C. G., Mathias B. J., Pietrow P. K., Albala D. M., Preminger G. M., A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 2008 71 5 792 795 2-s2.0-42749090635 10.1016/j.urology.2007. 11.004
33. Park S. C., Jung S. W., Lee J. W., Rim J. S., The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms. Journal of Endourology 2009 23 11 1913 1917 2-s2.0-70449427308 10.1089/end.2009.0173
34. Lim K. T., Kim Y. T., Lee T. Y., Park S. Y., Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean Journal of Urology 2011 52 7 485 488 2-s2.0-79961235958 10.4111/kju.2011.52.7.485
35. Lee S. J., Yoo C., Oh C. Y., Lee Y. S., Cho S. T., Lee S. H., Yang D. Y., Lee S. K., Cho J. S., Stent position is more important than α -blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: a prospective randomized study. Korean Journal of Urology 2010 51 9 636 641 2-s2.0-77956922989 10.4111/kju.2010.51.9.636